Evidence map›Paper›PMID 38735004›Full record

ArticleArchives of toxicology2024

Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.

Liesl K Janssens, Katleen Van Uytfanghe, Jeffrey B Williams, Kirk W Hering, Donna M Iula, Christophe P Stove

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
  3. In Vitro Metabolism of ΔDrug testing and analysis · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liesl K JanssensLaboratory of Toxicology, Department of Bioanalysis - Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0001-9740-5036
Katleen Van UytfangheLaboratory of Toxicology, Department of Bioanalysis - Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.ORCID 0000-0001-8195-150X
Jeffrey B WilliamsForensic Chemistry Division, Cayman Chemical Company, Ann Arbor, MI, 48108, USA.
Kirk W HeringForensic Chemistry Division, Cayman Chemical Company, Ann Arbor, MI, 48108, USA.
Donna M IulaForensic Chemistry Division, Cayman Chemical Company, Ann Arbor, MI, 48108, USA.
Christophe P StoveLaboratory of Toxicology, Department of Bioanalysis - Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. christophe.stove@ugent.be.ORCID 0000-0001-7126-348X

Funding

Bijzonder Onderzoeksfonds UGent BOF20/DOC/051
6 · The paper itself

Abstract

Cultivation of industrial low-Δ

Indexed as

beta-Arrestin 2CannabinoidsCannabisBiological AssayHEK293 CellsHumansIsomerismReceptor, Cannabinoid, CB1Structure-Activity RelationshipARRB2 protein, humanbeta-Arrestin 2CannabinoidsReceptor, Cannabinoid, CB1BioassayHHCPharmacological characterizationPhytocannabinoidsSemisynthetic cannabinoidsToxicology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.